Agilent Insider Trades and New Pharma Breakthroughs: What Clinicians Should Know
Agilent Technologies insider trading insights: May Simon sold 368 shares at $115.62, reflecting routine portfolio moves, while emerging oncology and antiviral therapies—like ADCs, pibrentasvir, and mRNA influenza vaccines—offer new treatment options…
4 minutes to read